Skip to content

Usability of a Novel Cueing Device for Patients With Parkinson's Disease

Usability Study of a Novel Tactile Cueing Device for Patients With Parkinson's Disease: A Monocentric Interventional Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04459559
Acronym
TCP
Enrollment
16
Registered
2020-07-07
Start date
2020-11-16
Completion date
2024-12-31
Last updated
2024-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Freezing of Gait, Parkinson Disease

Brief summary

Hypokinetic gait disorder and Freezing of Gait (FOG) are frequent symptoms in the advanced stage of Parkinson's disease (PD). These impair quality of life and significantly increase the risk of falls. External movement pacemakers have been developed to improve gait and avert FOG by cueing strategies. The investigators developed a smart, small and lightweight, easy-to-handle wearable tactile cueing device (TCD), consisting of a control unit, two pulse generators and a battery-driven power supply. The device is programmed via a Graphical User Interface (GUI).

Interventions

DEVICETactile Cueing Device

Each participant receives an individual training on how to use the Tactile Cueing Device and the set-up of the TCD will be done according to the results of a 10MWT and the participant's preferences. Gait assessments with an activated or deactivated TCD are executed using the Timed Up and Go test, the 2-Minute Waling test and a treadmill (C-Mill). Also a long-term test run of the TCD during one day is planned.

Sponsors

Rehaklinik Zihlschlacht AG
CollaboratorOTHER
Swiss Federal Institute of Technology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The proposed trial is designed as an explorative, open label, non-randomised, uncontrolled clinical trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Include patients who suffer from advanced PD. Characteristic symptoms of parkinsonian gait like hypokinetic movements and/or FOG have to be present. * Parkinsonian gait is measured by the following items of the Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS): item 2.12, item 2.13, item 3.10 and item 3.11. The Hoehn and Yahr (HY) stage during ON is 1-4/5. * MoCA ≥ 22/30. * Participant has signed the informed consent.

Exclusion criteria

* Inability of the participant to understand the IC or to follow the procedures of the study (as judged by the Qualified Physician). * Significantly, impaired cognitive skills render the participant unable to use the TCD. * Presence of severe motor fluctuations and severely impaired walking ability as defined by HY stage V during ON. * Clinically relevant skin lesions on the wrist or fixation points (usually the thighs).

Design outcomes

Primary

MeasureTime frameDescription
Setup cueing device2 weeksTime needed for the setup \[in seconds\] and the variations of the different setup parameters (cueing length \[seconds\], cueing strength \[% of maximum\], cueing cadence \[count/minutes\]) between the days of usage. Overall descriptive summary of the variation between the different setup parameters during the days of usage.
System Usability Scale2 weeksItems defined by the System Usability Scale: 5-point Likert scale ('strongly disagree' to 'strongly agree').
Usability2 weeksUsability of the cueing device is measured by a self-developed questionnaire.
Acceptance2 weeksAcceptance is measured by a self-developed questionnaire.
Frequency using the device2 weeksHow often the device is used (counts logging protocol).

Secondary

MeasureTime frameDescription
Walking speed [meters/second]1 weekCalculated by the assessments 10 meter walk test and 2-minute walk test.
Number of FOG1 weekExtracted from video documentation by a blinded rater.
Cadence [steps/minute]1 weekNumber during 10 meter walk test. Also measured by a system of movement analysis (C-Mill MOTEK).
Walking distance [in meters]1 weekMeasured by a digital measuring wheel during 2-minute walk test. Also measured by a system of movement analysis (C-Mill MOTEK).
Step length right/left [in meters]1 weekMeasured by a system of movement analysis (C-Mill MOTEK).
Initial step latency [in seconds]1 weekExtracted from video documentation by a blinded rater.

Countries

Switzerland

Contacts

Primary ContactRaoul Schweinfurther, M.A.
r.schweinfurther@rehaklinik-zihlschlacht.ch+41 71 424 3118
Backup ContactCarsten Möller, Prof.
C.Moeller@rehaklinik-zihlschlacht.ch+41 71 424 3021

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026